Mark Stolper - Director at Coherus Oncology, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
CHRS on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Mark Stolper since 21 Oct 2025

Reported holdings for Mark Stolper in Coherus Oncology, Inc.

Form 4 holding Director

Coherus BioSciences, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
112,000
Estimated value
Report date
03 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Mark Stolper in Coherus Oncology, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .